Scottish swimmer Archie Goodburn will meet Prime Minister Andy Burnham on Wednesday, highlighting the urgent need for action on brain tumours, reports BritPanorama.
Goodburn, 25, who was diagnosed with an oligodendroglioma at age 22, has advocated for greater support and recognition for brain tumour patients following a heartfelt appeal. He expressed that his advocacy has enabled him to engage in vital discussions with government officials about the challenges faced by the brain tumour community.
His advocacy highlights significant issues in the UK, such as the absence of international clinical trials and a lack of urgency in appointing a national brain cancer lead. In a poignant moment during a public appearance, Goodburn implored for investment in research and treatments, stating, “Please invest and make the difference. I’m on my knees begging for not just my own life but those who are affected and the families all around the country.” His remarks underline the pressing need for change, as he described the ongoing suffering caused by insufficient action on brain tumours.
Burnham responded by inviting Goodburn for a meeting, which will be an opportunity for the athlete to share his experiences and push for necessary reforms in brain cancer treatment and research.
In an earlier interview with the charity Brain Tumour Research, Goodburn recounted his journey to diagnosis, which began with a seizure in December 2023. Initially misdiagnosed, he faced numerous challenges before eventually opting for a private MRI scan that confirmed his condition. He described the moment as overwhelming, stating, “I just couldn’t believe I had cancer, it made no sense.” The tumour type he was diagnosed with is notoriously difficult to treat, leading to a “watch and wait” care pathway due to the potentially devastating side effects of conventional therapies.
After further investigation, Goodburn was able to access a treatment called vorasidenib through a managed access programme, which he commenced in summer 2025 and described as “transformational.” However, he expressed concern about the lack of alternative treatments available in the UK, as similar patients in places like the United States have access to additional therapies.
His quest for improvement in treatment options is underscored by his academic accomplishments, having graduated with first class honours from the University of Edinburgh. Goodburn has also competed successfully in swimming at events including the Commonwealth Games. Nonetheless, he fears for the future, stating, “If vorasidenib fails then currently there is no ‘plan B’ or ‘next line’ of treatment in this country.”
Goodburn’s upcoming meeting is not only significant for his personal battle but for the broader advocacy movement. He emphasized the collective voice of the brain tumour community, stating, “We cannot accept the status quo in the system, we cannot be risk-averse. People are dying.” Experts believe this meeting represents a potential turning point, with a call for increased government commitment to brain tumour research and funding. An open letter from Brain Tumour Research, supported by medical professionals, stresses the necessity for a “step change” in government funding and support for brain tumour initiatives.
Currently, approximately 12,500 people in the UK are diagnosed with a brain tumour annually, with a significant proportion of funding for research originating from charities rather than governmental sources.
The dialogue initiated by Goodburn’s meeting with the Prime Minister could shape the future landscape of brain tumour treatment in the UK, as the urgency for systemic change grows. Addressing this issue is key, as advancements in research and funding can make a profound difference for countless patients.
